Nasal Drug Delivery

Key Topics

• Particulate Vaccine Delivery Systems
• Nasal and Buccal Drug Delivery Devices
• Nasal Drugs to Treat Nasal Disorders
• New Developments in the Assessment of the Performance of Nasal and Regulatory Requirements
• Overcoming Barriers in Nasal Dry Powder Delivery Development
• Current Nasal Powder Technologies: The Challenge of Powder Dosing
• The Best Way to Finance Company R&D Collaborations for Drug Delivery: Legal and Contractual Issues
• Advancia: Innovative Design Solution to Respond to New Challenges in Nasal Delivery

Who should Attend

• Medical Directors
• Managing Directors
• Senior Executives in Research and Development
• Head of Regulatory Affairs and Quality Assurance
• Marketing and all departments that may be involved in Nasal Drug Delivery
• Registration